Data / Research funding / Wisconsin / Morgridge Institute for Research, Inc.
Morgridge Institute for Research, Inc.: 16 NIH awards ($17.3M) and 7 NSF awards ($18.9M), fiscal years 2021 to 2026
Morgridge Institute for Research, Inc. in Madison, WI is funded under 16 NIH awards ($17.3M) and 7 NSF awards ($18.9M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- W6Q8XJV41Z98
- State
- Wisconsin
Awards
23 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Category I: Fabric for AI-Driven Science (FabAID) | NSF | Office of Advanced Cyberinfrastructure | 2026 | $9,000,000 | May 15, 2026 | April 30, 2031 | Brian P Bockelman | nsf.gov |
| Pelican: Advancing the Open Science Data Federation Platform | NSF | Office of Advanced Cyberinfrastructure | 2023 | $7,725,627 | September 1, 2023 | August 31, 2027 | Brian P Bockelman | nsf.gov |
| Functional optical imaging for rapid, label-free predictions of treatment response and clonal evolution in patient-derived cancer organoids | NIH | National Cancer Institute | 2023 to 2025 | $2,348,049 | April 1, 2023 | March 31, 2028 | SKALA, MELISSA CAROLINE | reporter.nih.gov |
| Transplantation of MHC Homozygous Vascular Progenitors in Primates | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,302,970 | September 20, 2016 | May 31, 2025 | SLUKVIN, IGOR I. | reporter.nih.gov |
| Label-free imaging of CAR T cell metabolism | NIH | National Cancer Institute | 2023 to 2025 | $1,924,868 | August 1, 2023 | July 31, 2028 | SKALA, MELISSA CAROLINE | reporter.nih.gov |
| Label-free single-cell imaging for quality control of cardiomyocyte biomanufacturing | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,900,815 | April 1, 2023 | March 31, 2027 | SKALA, MELISSA CAROLINE | reporter.nih.gov |
| Metabolic rewiring coupled to the production of reactive oxygen and nitrogen species (RONS) | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,705,120 | August 1, 2022 | June 30, 2027 | FAN, JING | reporter.nih.gov |
| A Machine Learning Platform for Adaptive Chemical Screening | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,669,730 | September 14, 2020 | August 31, 2025 | GITTER, ANTHONY JAMES | reporter.nih.gov |
| Leveraging zebrafish models to dissect and enhance heart regeneration | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,448,175 | May 15, 2020 | April 30, 2027 | POSS, KENNETH D | reporter.nih.gov |
| Germ cell specification and differentiation in planarians | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $865,248 | January 9, 2003 | April 30, 2030 | NEWMARK, PHILLIP A | reporter.nih.gov |
| Collaborative Research: BeeHive: A Cross-Problem Benchmarking Framework for Network Biology | NSF | Infrastructure, Institutes, & Centers | 2023 | $704,368 | May 1, 2023 | April 30, 2027 | Anthony Gitter | nsf.gov |
| Elements: Kingfisher: Storage Management for Data Federations | NSF | Office of Advanced Cyberinfrastructure | 2022 | $599,261 | July 1, 2022 | June 30, 2027 | Brian P Bockelman | nsf.gov |
| Optical imaging of pancreas cancer organoids for drug development and personalized treatment | NIH | National Cancer Institute | 2021 | $554,862 | August 1, 2017 | July 31, 2023 | SKALA, MELISSA CAROLINE | reporter.nih.gov |
| Regulation of Appendage Regeneration in Zebrafish | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $525,400 | June 15, 2021 | May 31, 2026 | POSS, KENNETH D | reporter.nih.gov |
| Mechanisms of Mitral Cell Regeneration in Zebrafish | NIH | National Institute on Deafness and Other Communication Disorders | 2025 | $495,000 | August 1, 2025 | July 31, 2027 | POSS, KENNETH D | reporter.nih.gov |
| Development and Validation of Photothermal Optical Coherence Tomography for Retinal Imaging | NIH | National Eye Institute | 2022 to 2023 | $480,135 | February 1, 2022 | January 31, 2025 | SKALA, MELISSA CAROLINE | reporter.nih.gov |
| Collaborative Research: MFB: Integrating Deep Learning and High-throughput Experimentation to Rapidly Navigate Protein Fitness Landscapes for Non-native Enzyme Catalysis | NSF | Chemistry Section | 2022 | $444,038 | November 1, 2022 | October 31, 2026 | Anthony Gitter | nsf.gov |
| Understanding the interplay of genetic and environmental contributions to human cell fitness | NIH | National Institute of General Medical Sciences | 2025 | $421,600 | January 1, 2025 | December 31, 2029 | CANTOR, JASON ROBERT | reporter.nih.gov |
| Defining the Robustness of Zebrafish Spinal Cord Regeneration | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $270,000 | April 17, 2025 | March 31, 2027 | POSS, KENNETH D | reporter.nih.gov |
| Collaborative Research: Image-based Readouts of Cellular State using Universal Morphology Embeddings | NSF | Division of Biological Infrastructure | 2024 | $256,667 | October 1, 2023 | April 30, 2025 | Juan C Caicedo | nsf.gov |
| Dynamic Metabolic Reprogramming in Macrophages during Immune Response | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $236,066 | February 9, 2022 | January 31, 2024 | FAN, JING | reporter.nih.gov |
| Use of Physiologic Media to Study Metabolic Regulation and Requirements in Cancer | NIH | National Cancer Institute | 2021 | $189,797 | April 1, 2019 | March 31, 2022 | CANTOR, JASON ROBERT | reporter.nih.gov |
| Collaborative Research: EAGER: Autofluorescence lifetime flow sorting with time-correlated single photon counting | NSF | Chemical, Bioengineering, Environmental, & Transport Systems | 2024 | $125,805 | August 1, 2024 | July 31, 2026 | Melissa C Skala | nsf.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2026 | 0 | $0 | 1 | $9,000,000 |
| 2025 | 10 | $5,608,631 | 1 | $1,717,986 |
| 2024 | 7 | $3,328,217 | 3 | $1,086,826 |
| 2023 | 6 | $3,080,504 | 2 | $5,750,988 |
| 2022 | 6 | $2,720,501 | 3 | $1,299,966 |
| 2021 | 5 | $2,599,982 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 2 awards here | |
| NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) | PAR-27-089 | NIH | 93.394 | November 2, 2026 | Not listed | Same assistance listing 93.394 as 3 awards here |
| Autism Centers of Excellence R01 | RFA-HD-27-001 | NIH | 93.865 | November 2, 2026 | Not listed | Same assistance listing 93.865 as 3 awards here |
| Autism Centers of Excellence P50 | RFA-HD-27-002 | NIH | 93.865 | November 2, 2026 | Not listed | Same assistance listing 93.865 as 3 awards here |
| Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | RFA-CA-27-001 | NIH | 93.394 | November 10, 2026 | $150,000 | Same assistance listing 93.394 as 3 awards here |
| Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | RFA-CA-27-002 | NIH | 93.394 | November 10, 2026 | $300,000 | Same assistance listing 93.394 as 3 awards here |
| Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional) | RFA-OD-27-009 | NIH | 93.859 | November 10, 2026 | Not listed | Same assistance listing 93.859 as 3 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.865 | November 16, 2026 | $50,000 | Same assistance listing 93.865 as 3 awards here |
| National Science Foundation Translation to Practice (NSF TTP) | 25-540 | NSF | 47.070 | November 17, 2026 | $2 million | Same assistance listing 47.070 as 3 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.865 | November 18, 2026 | Not listed | Same assistance listing 93.865 as 3 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.865 | November 18, 2026 | Not listed | Same assistance listing 93.865 as 3 awards here |
| NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed) | PAR-27-088 | NIH | 93.394 | November 20, 2026 | Not listed | Same assistance listing 93.394 as 3 awards here |
| HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) | RFA-AT-25-003 | NIH | 93.865 | November 23, 2026 | $375,000 | Same assistance listing 93.865 as 3 awards here |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | 93.865 | November 24, 2026 | Not listed | Same assistance listing 93.865 as 3 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.837 | December 3, 2026 | Not listed | Same assistance listing 93.837 as 3 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.837 | December 3, 2026 | Not listed | Same assistance listing 93.837 as 3 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.865 | December 4, 2026 | Not listed | Same assistance listing 93.865 as 3 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.865 | January 5, 2027 | Not listed | Same assistance listing 93.865 as 3 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.865 | January 5, 2027 | Not listed | Same assistance listing 93.865 as 3 awards here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.865 | January 7, 2027 | $375,000 | Same assistance listing 93.865 as 3 awards here |
Topics of its NIH awards
- Bioengineering
- Biotechnology
- Regenerative Medicine
- Genetics
- Cancer
- Stem Cell and Progenitor Cell Research
- Clinical Research
- Translational Research
- Biomedical Imaging
- Neurosciences
- Adult/Somatic Stem Cell and Progenitor Cell Research
- Digestive Diseases
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.